Selected Publications
- Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6). Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva, Joseph A. Murray. Archives of Dermatological Research
- Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients. Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva, Joseph A. Murray. Archives of Dermatological Research
- Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo. Jesus Gay-Mimbrera, Daniel Lozano-Ojalvo, Pedro J. Gómez-Arias, Irene Rivera-Ruiz, Macarena Aguilar-Luque, Carmen Mochón-Jiménez, Eloísa Andújar Pulido, Mónica Pérez-Alegre, Emma Guttman-Yassky, Juan Ruano. British Journal of Dermatology